How Is Nailfold Capillaroscopy Used in UCTD and Raynaud's?

Nailfold capillaroscopy is a safe, painless, and non-invasive test that examines the tiny blood vessels (capillaries) at the base of your fingernails ^[1].

In people with Undifferentiated Connective Tissue Disease (UCTD)—a term for autoimmune symptoms or test findings that do not yet fit a specific named disease—or Raynaud’s phenomenon (fingers turning white, blue, or red in the cold), this test helps doctors evaluate microvascular health ^[1][2]. By looking closely at these vessels, doctors can look for clues about whether your symptoms are isolated or part of a broader systemic condition, such as systemic sclerosis (scleroderma) ^[3].

Preparing for the Test

To ensure the images are clear and accurate, clinics typically ask you to follow a few simple preparation steps ^[1][3]:

• Remove nail products: Do not wear nail polish, gel, or acrylic nails to the appointment.
• Avoid trauma: Avoid manicures or pushing back your cuticles in the weeks leading up to the test, as this can damage the vessels and make them harder to interpret.
• Stay warm: The clinic will usually have you wait in a room-temperature area for 15 to 20 minutes before the test to allow your blood vessels to acclimatize and open up.
• Medications: Do not stop taking your Raynaud’s or autoimmune medications unless your doctor explicitly tells you to do so.

Always prioritize your specific clinic’s instructions.

What Happens During the Test?

The procedure is quick and involves no needles. A doctor or technician will place a drop of oil or gel at the base of your fingernails to make the skin more transparent ^[1][4]. They will then use a magnifying device to look at the blood vessels just beneath the surface ^[1].

Ideally, this is done using videocapillaroscopy, a specialized, high-magnification microscope connected to a screen that provides highly detailed, standardized images ^[4][3]. If that is not available, a doctor might use a dermatoscope (a lighted magnifier used by dermatologists) or a USB microscope for screening, though these are less standardized ^[1][3].

What the Doctor is Looking For

The examiner evaluates the overall combination of vessel shapes, sizes, and density, rather than just a single abnormality ^[1][4].

• A Normal Pattern: The capillaries look like an orderly, parallel row of tiny hairpins ^[5].
• Nonspecific Changes: The loops might cross, look slightly twisted, or show minor variations. These nonspecific findings can occur in healthy individuals, people with primary Raynaud’s, or those with UCTD ^[5][6].
• The “Scleroderma Pattern”: This characteristic pattern involves a combination of abnormal findings: significantly enlarged (“giant”) capillaries, tiny bleeding spots (microhemorrhages), disorganized vessel growth, and capillary loss (areas where fewer capillaries are visible) ^[4][5]. Depending on the severity, reports may describe this pattern as “early,” “active,” or “late” ^[5][7].

Why is it Used in UCTD and Raynaud’s?

1. Differentiating Primary from Secondary Raynaud’s

Raynaud’s phenomenon can be primary (usually not associated with an underlying systemic disease) or secondary (associated with another condition or medication) ^[3]. Secondary causes include autoimmune connective-tissue diseases, but also occupational vibration, vascular diseases, and certain medications ^[3].

A normal capillaroscopy makes an autoimmune microvascular disease like systemic sclerosis less likely, though it does not completely rule out early disease or other secondary causes ^[3][2]. Conversely, damaged vessels increase the likelihood that the Raynaud’s is secondary ^[3].

2. Assessing the Risk of Progression

For patients with UCTD, finding a scleroderma pattern raises the suspicion that the condition might progress toward systemic sclerosis or another connective tissue disease ^[8][9].

However, capillaroscopy is a risk marker, not a crystal ball ^[10]. An abnormal pattern identifies a higher-risk group, but it does not establish a diagnosis of systemic sclerosis on its own, guarantee that your disease will progress, or tell you when progression might happen ^[10][8].

Doctors combine these visual findings with your physical symptoms (like puffy fingers) and blood tests (such as ANA and systemic-sclerosis-specific antibodies like anti-centromere, Scl-70, or anti-RNA polymerase III) ^[10][11]. Research shows that the combination of specific antibodies, puffy fingers, and abnormal capillaroscopy is a stronger predictor of progression than any single factor ^[10].

What Your Result Can and Cannot Tell You

Limitations of the Test

• It is not a stand-alone diagnosis: A scleroderma-like pattern can also occur in mixed connective tissue disease (MCTD), inflammatory myopathies (like dermatomyositis), and lupus ^[14][15].
• Results depend on the equipment: Standardized videocapillaroscopy is the preferred method ^[16]. Handheld dermatoscopes or consumer USB microscopes are not meant for diagnosing systemic sclerosis at home, and they can yield blurry images ^[16][17].
• Results depend on the examiner: Interpreting the details of micro-vessels requires specific training. Accuracy relies heavily on the operator’s experience ^[18].
• Skin tone can impact image contrast: Studies show that lower-magnification devices (like dermatoscopes) frequently produce blurry or hard-to-interpret images in people with darker skin tones ^[17]. This is an equipment limitation, not an inherent inability to assess darker skin; it can usually be resolved with proper lighting, high-quality videocapillaroscopy, and expert review ^[17][16].

🛑 When to Contact Your Doctor Promptly

While capillaroscopy is a routine monitoring test, do not wait for your next appointment if you develop serious symptoms. Contact a clinician promptly if you experience:

• New, painful sores or ulcers on your fingertips
• Blackening or persistent dark discoloration of a finger
• Severe, unrelenting finger pain
• Signs of infection in the fingers
• New or worsening shortness of breath, chest pain, or difficulty swallowing